Fig. 4: Distribution of AEL values of molecularly targeted agents (MTAs) assigned by the digital drug assignment (DDA) used in the SHIVA01 trial.
DDA AEL scores of MTAs used in SHIVA01 patients with progressive disease (PD) (blue bars) and patients achieving DCR (red bars).
